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ABSTRACT
The lateral stalk of ribosome is responsible for
kingdom-specific binding of translation factors and
activation of GTP hydrolysis that drives protein syn-
thesis. In eukaryotes, the stalk is composed of
acidic ribosomal proteins P0, P1 and P2 that consti-
tute a pentameric P-complex in 1: 2: 2 ratio. We have
determined the solution structure of the N-terminal
dimerization domain of human P2 (NTD-P2), which
provides insights into the structural organization of
the eukaryotic stalk. Our structure revealed that eu-
karyotic stalk protein P2 forms a symmetric
homodimer in solution, and is structurally distinct
from the bacterial counterpart L12 homodimer. The
two subunits of NTD-P2 form extensive hydrophobic
interactions in the dimeric interface that buries 2400
A˚2 of solvent accessible surface area. We have
showed that P1 can dissociate P2 homodimer spon-
taneously to form a more stable P1/P2 1 : 1
heterodimer. By homology modelling, we identified
three exposed polar residues on helix-3 of P2 are
substituted by conserved hydrophobic residues in
P1. Confirmed by mutagenesis, we showed that
these residues on helix-3 of P1 are not involved in
the dimerization of P1/P2, but instead play a vital
role in anchoring P1/P2 heterodimer to P0. Based
on our results, models of the eukaryotic stalk
complex were proposed.
INTRODUCTION
The large subunit of ribosome has a lateral protuberance
known as the ribosomal stalk, which is responsible for
kingdom-specific binding of translation factors and
activation of GTP hydrolysis (1,2). The structural com-
position of bacterial, archaeal and eukaryotic stalks is dif-
ferent. In bacteria, the stalk consists of ribosomal protein
L10 in complex with two or three homodimers of L12
(3,4). In archaeal stalk, L10 is replaced by acidic riboso-
mal protein P0, which in turn binds three copies of
homodimers of P1 (5). The composition of eukaryotic
stalk is the most complex, which involves the formation
of a pentameric P-complex consisting of acidic ribosomal
proteins P0, P1, P2 in 1: 2: 2 ratio (6). Although early
cross-linking experiments suggested the presence of
homodimers of P1 and P2 in the eukaryotic P-complex
(6), current view favours the model of two copies of
P1/P2 heterodimers binding to the C-terminal domain of
P0 to form the P0-(P1/P2)2 complex (7,8). The whole
P-complex is anchored to the 28S rRNA via the
N-terminal domain of P0, which is homologous to the
RNA binding domain of L10 (9,10). Eukaryotic P1 and
P2 proteins also exist in free form in the cytoplasm, and
the exchange between the ribosome-bound and the cyto-
plasmic pools plays a role in regulating the activity of eu-
karyotic ribosomes (11).
All P-proteins contain a conserved motif at C-terminus
that is responsible for binding elongation factors (12) and
ribosome-inactivating proteins (13–15). We have recently
solved the crystal structure of the C-terminal conserved
motif (SDDDMGFGLFD) of human P-proteins in
complex with trichosanthin, a ribosome-inactivating
protein, and showed that the two proteins form specific
interactions (16). Unlike the flexible C-terminal domain,
the N-terminal domains of P1 and P2 form well-ordered
helical structures (17), and are involved in the formation
of P1/P2 heterodimer (7,18). The P1/P2 heterodimers are
anchored to two separate regions in the C-terminal
domain of P0 to form the pentameric P-complex (19,20).
P2 also exists as a homodimer in the free form (6,21,22),
and its N-terminal domain was found to be responsible for
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dimerization (7,18,21). Both P1 and P2 are found in the
cytoplasmic pool, which are exchanging with those on the
ribosome (11). In the absence of P2, P1 is rapidly degraded
in yeast (23). Suppression of P2 expression by RNA inter-
ference in human cell lines also leads to the depletion of P1
protein (24). These observations suggest that P2 protects
P1 from degradation, probably through the formation of
P1/P2 heterodimer. To date, high-resolution structure of
any eukaryotic P-proteins is not available. To provide
better insights into the structural organization of eukary-
otic stalk, we have determined the structure of the
N-terminal dimerization domain of P2 by nuclear
magnetic resonance (NMR) spectroscopy. By homology
modelling, a structural model of P1/P2 dimerization
domain was proposed and this model correctly predicted
that helix-3 of P1 does not involved in P1/P2 dimerization,
but plays an important role in the formation of
P-complex. Finally, models of the structural organization
of eukaryotic stalk were proposed.
MATERIALS AND METHODS
Construction of mutants
The DNA fragments coding for NTD-P1 and NTD-P2
were amplified by PCR using the wild-type expression
vectors, pET8c-P1 and pET8c-P2, as templates. NcoI-
BamHI digested DNA fragment of NTD-P2 was inserted
into pET8c. AgeI-BamHI-digested DNA fragment of
NTD-P1 was inserted into an in-house pRSETA-
HisSUMO (poly-His-small-ubiquitin-like-modifier)
vector, with an N-terminal His-SUMO tag. To create
the P1TM mutant, triple mutations (F42D/W43R/
L46K) were introduced to the pET8c-P1 using the
QuikChange site-directed mutagenesis kit (Stratagene)
according to manufacturer instructions. For His-tagged
P0, BamHI-EcoRI digested DNA fragment of P0 was
inserted into pRSETA vector with an N-terminal
poly-histidine tag. Sequences of primers used were
summarized in Supplementary Table S1.
Sample preparation
Preparation of NMR samples of NTD-P2. NTD-P2 was
expressed in Escherichia coli strain BL21(DE3)pLysS
(Novagen) in M9 medium (6 g/l Na2HPO4, 3 g/l
KH2PO4, 0.5 g/l NaCl, 2mM MgSO4) containing 2 g/l
13C glucose and/or 1 g/l 15N ammonium chloride and ap-
propriate antibiotics (100 mg/ml ampicilin and 50 mg/ml
chloramphenicol). To prepare 10% 13C labelled sample,
1.8 g/l 12C glucose plus 0.2 g/l 13C glucose were used
instead. Bacterial cells were grown in 37C until OD600
reached 0.4–0.8, when the expression was induced by
0.4mM isopropyl beta-D-1-thiogalactopyranoside
(IPTG). The cells were harvested after 4 h by centrifuga-
tion at 6000g at 4C for 10min.
After sonication, the cell lysate was loaded to a
diethylaminoethyl (DEAE)-Sepharose column
equilibrated with 20mM Tris/HCl, pH 8.5. A 200ml
linear gradient of 0–0.3M NaCl was used to elute
NTD-P2. Protein fractions from DEAE-Sepharose
column were concentrated to 5ml before loading to a
HiLoad 26/60 Superdex 75 column (GE Healthcare)
pre-equilibrated with 20mM Tris/HCl, 0.2M NaCl at
pH 8.5. Fractions containing the NTD-P2 were pooled,
dialysed against 20mM Tris/HCl at pH 8.5, and then
loaded to a 5ml HiTrap diethylaminopropyl (ANX)
column. A gradient of 0–0.2M NaCl over 200ml was
used to elute the protein and NTD-P2 was eluted at
about 0.1M NaCl. Typical yield for NTD-P2 is 15mg/l
of bacterial culture.
To prepare asymmetrically labelled NTD-P2 for obtain-
ing intermolecular NOEs, 20 mM unlabelled NTD-P2 was
mixed with 10 mM 13C/15N labelled NTD-P2, denatured in
8M urea, 0.2M Na2SO4, 20mM Tris/HCl buffer at pH
7.5, and co-refolded by dialysis against 0.2M Na2SO4,
20mM Tris/HCl buffer at pH 7.5. Refolded protein
complex was concentrated to 1.7mM in 0.2M
Na2SO4, 20mM D11-Tris/HCl buffer pH 7.5 in D2O.
Preparation of NTD-P1/NTD-P2 complex. NTD-P1 was
expressed as a fusion protein with an N-terminal
His-SUMO tag. His-SUMO-tagged NTD-P1 was ex-
pressed as inclusion bodies in E. coli, which was washed
by 0.1% TritonX-100, 0.1% NP-40, 0.15M NaCl, 20mM
sodium phosphate buffer (PB) at pH 7.4 and dissolved in
8M urea, 0.15M NaCl, 20mM PB at pH 7.4. After puri-
fication by metal-chelating chromatography, 10 mM of
urea-denatured His-SUMO-NTD-P1 was mixed with
20 mM NTD-P2, and co-refolded by dialysis against
0.15M NaCl, 20mM PB, pH 7.4. Refolded complex of
His-SUMO-NTD-P1/NTD-P2 was purified by
metal-chelating chromatography. His-SUMO tag was
removed by SUMO protease digestion followed by
metal-chelating chromatography. NTD-P1/NTD-P2 was
further purified by gel filtration using a Superdex 75
column.
Preparation of P1/P2 and P1TM/P2 complex. Cell lysates
of P1 or P1TM were loaded to Q fast flow column
pre-equilibrated with 20mM Tris/HCl, pH 7.8. P1 and
P1TM collected in flow-through were precipitated by
40% ammonium sulphate. The precipitate was resus-
pended in 8M urea, 20mM Tris/HCl buffer at pH 7.8
and loaded to HiTrap Q HP column pre-equilibrated
with the same buffer. P1 or P1TM were eluted by a
200ml gradient of 0–0.5M NaCl. After removal of urea
by dialysis, P1 or P1TM was mixed with P2 (purified as
described previously (13)) in 1: 1 molar ratio and was
incubated at 4C for 15min to yield P1/P2 or P1TM/P2
complex.
Co-refolding of Poly-histidine-tagged P0 with P1/P2 or
P1TM/P2
His-tagged P0 was expressed as inclusion bodies in E. coli.
After expression, the inclusion bodies was washed with
0.1% TritonX-100, 0.1% NP-40 in buffer A (0.5M
NaCl, 20mM Tris/HCl buffer at pH 7.8), dissolved in
4M guanidine hydrochloride, and then loaded to a
nickel-chelating column pre-equilibrated with 8M urea
in buffer A. His-tagged P0 was eluted by a linear
gradient of 0–300mM imidazole in 8M urea, buffer A.
10 mM of purified His-tagged P0 was mixed with 30 mM
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of purified complex of P1/P2 or P1TM/P2. The proteins
were denatured in 8M urea, and co-refolded by dialysing
against buffer A. His-tagged P0 was refolded alone as a
control. After co-refolding, the protein samples were
centrifuged, and were analysed by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS–PAGE).
To purify His-tagged P0/P1/P2 complex, the co-refolded
protein sample was loaded to a nickel-chelating column
pre-equilibrated with buffer A. The complex was eluted by
300mM imidazole in buffer A.
Structure determination of NTD-P2 by NMR
spectroscopy
NMR spectra were collected in a Varian Unity Inova
500MHz or Bruker Avance 600MHz spectrometers at
298K. Sequential assignment of backbone resonances
was obtained by Ca and Cb connectivities generated by
the HNCACB and the CBCA(CO)NH experiments.
Side-chain resonances were obtained from
TOCSY-HSQC, HC(CCO)NH, HCCH-TOCSY and
HCCH-COSY experiments. Stereo-specific assignment of
methyl groups of Val and Leu were based on a constant
time 1H-13C HSQC experiment acquired on a 10%
13C-labelled protein sample. The aromatic side-chains of
Y3 and Y7 were obtained from 2D homonuclear
DQF-COSY and TOCSY experiments. Inter-proton re-
straints (NOEs) were obtained from NOESY-type experi-
ments such as 1H,15N NOESY-HSQC, 1H,15N
HSQC-NOESY-HSQC, 1H,13C-NOESY-HSQC, 1H,13C
HSQC-NOESY-HSQC and 2D homonuclear NOESY.
Intermolecular NOEs were obtained from the
13C-filtered/13C-edited NOESY (25) acquired on an asym-
metrically labelled protein sample of NTD-P2 homodimer.
Chemical shifts were referenced with respect to DSS. All
multidimensional NMR data were processed with the
NMRPipe (26) and analysed using the NMRView
software (27). Dihedral angle restraints were derived
from the TALOS program (28). Hydrogen bond restraints
were deduced from deuterium exchange experiments, and
were only included for those protected amide groups in
helices. Structural calculation was performed using the
program ARIA 2.2 (29) and CNS 1.2 (30,31), with an
initial set of manually assigned NOEs. The structures
were converged in the first round of calculation.
ARIA-assigned NOEs were checked manually, and were
included in subsequent rounds of calculation iteratively.
Finally, the best 10 structures with the lowest total
energy, no NOE or dihedral angle violation were
selected. Structural abnormalities in all stages were
checked using the program PROCHECK (32).
Static light scattering
100ml of protein samples (2–4mg/ml) were loaded to an
analytical gel filtration column (Superdex 75 for NTD-P2
homodimer and NTD-P1/NTD-P2; Superdex 200 for P1/
P2, P1TM/P2 and P0/P1/P2 complexes) connected to a
miniDawn light scattering detector and an Optilab DSP
refractometer (Wyatt Technologies). The protein complex
was eluted as a single peak. The light scattering data were
analysed using the ASTRA software provided by the
manufacturer to obtain the molecular mass of the
protein complex.
Circular dichroism spectroscopy
Circular dichroism spectra were measured on a JASCO
J-810 spectropolarimeter at 298K using a quartz cuvette
of 0.1 cm path length. The protein sample concentration
was 0.2mg/ml. The spectra were averages of three scans,
and were reported as molar ellipticity.
Urea-induced denaturation
Protein samples (0.2mg/ml) were equilibrated with
0–7.5M of urea in 10mM sodium phosphate buffer at
pH 7.4 at 25C. Protein unfolding was monitored by
molar ellipticity at 222 nm at 298K using a 1-mm
path-length cuvette with a JASCO J810 spectropo-
larimeter. The denuatation was confirmed to be reversible.
The data were fitted by non-linear regression to a two-state
model to obtain the free energy of unfolding (33).
Model building
Models of human P1/P2 dimerization domain and its
complex with P0 C-terminal helix were generated by
MODELLER (34) using human NTD-P2 and Ph-P0/P1
complex (5) as template respectively. Model of human
P-complex built was fit to the extended stalk region of
the cryo-EM map of canine 80S ribosome (35) using
CHIMERA (36).
RESULTS
P2 forms homodimer and the N-terminal domain is
responsible for dimerization
We have constructed the N-terminal domain of human P2
(NTD-P2) by removing 46 residues from the C-terminus.
The molecular masses of both full-length P2 and NTD-P2
were analysed by static light scattering and were found to
be 22.5 and 13.5 kDa respectively (monomer molecular
mass are 11.5 and 7.2 kDa, respectively; Figure 1), sug-
gesting that both of them form homodimer and the
N-terminal domain is responsible for dimerization.
NMR structure of NTD-P2
To investigate the structural mechanism of dimerization,
we have determined the solution structure of NTD-P2 by
NMR spectroscopy. Statistics of structural calculation are
summarized in Table 1. NTD-P2 forms a symmetric
homodimer, and each monomer has four helices
(Figure 2A). The dimeric interface of human NTD-P2 is
formed by helices 1, 2 and 4 packing with each other in an
antiparallel fashion. Helix-3 is located away from the
interface and does not involve in dimerization
(Figure 2A). Highly conserved hydrophobic residues
Ala-5, Leu-8, Leu-9, Ile-26, Leu-27, Val-30, Ile-32 and
Ile-55 are located at the dimeric interface, which buries
1900 A˚2 of non-polar and 500 A˚2 of polar solvent ac-
cessible surface area (Figure 2B and C). From this point of
view, two monomers of NTD-P2 form an integral globular
structure consisting of eight helices, with helices 2, 3 and 4
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on the surface, and the highly hydrophobic helix-1 buried
in the middle of the dimer. In particular, the highly
conserved residues (Ala-5, Leu-8 and Leu-9) of helix-1
make a number of interactions in the dimeric interface
(Figure 2B). First, Ala-5 and Leu-9 form a ridge that fits
into the groove formed by Ala-5 and Leu-8 from the
opposite monomer, allowing helix-1 from each monomer
to pack according to the ridges-and-grooves model. The
Leu-8, on the other hand, is involved in interacting with
Ile-55 of helix-4 from the opposite monomer. Moreover,
Leu-9 of helix-1 fits nicely into the hydrophobic pocket
formed by the conserved residues Ile-26, Val-30 and
Ile-32 of helix-2 from the opposite monomer. These inter-
actions are supported by unambiguous intermolecular
NOEs observed (Figure 2D).
P1 and P2 form 1: 1 heterodimer spontaneously
We first showed that P1 formed heterodimer with P2 by
mixing P1 and P2. The formation of P1/P2 complex was
confirmed by native gel electrophoresis (Figure 3A) and
size-exclusion-chromatography/static-light-scattering
(Figure 3B). The molecular mass of P1/P2 complex was
determined to be 24 kDa (Figure 3B), suggesting P1 and
P2 form a 1: 1 heterodimer in solution (the molecular
masses of P1 and P2 are 11.5 and 11.6 kDa, respectively).
As P2 alone exists as a homodimer in solution, our data
imply that addition of P1 can dissociate P2 homodimer to
form a more stable 1: 1 P1/P2 heterodimer. To this end, we
measured the conformational stability (in terms of free
energy of unfolding) of P2 homodimer and P1/P2
heterodimer by urea-induced denaturation experiment. It
was found that P1/P2 heterodimer was more stable than
P2 homodimer, with free energy of unfolding of 13 kJ/mol
and 7 kJ/mol, respectively (Figure 3C). Our result suggests
the interaction between P1 and P2 is stronger than that
between P2 and P2, which justifies the observation that P1
can dissociate P2 homodimer to form P1/P2 heterodimer
spontaneously.
Helix-3 of P1 does not involve in P1/P2 dimerization but
is involved in P-complex formation
Previous studies suggested that the N-terminal domains of
P1 and P2 are involved in dimerization (18,22,37,38). We
have constructed the N-terminal domain of human P1
(NTD-P1) by removing 40 residues from the C-terminus.
Purified complex of NTD-P1/NTD-P2 was loaded to
Superdex 75 analytical gel filtration column, and the
molecular mass of the complex was determined to be
14.8 kDa by static light scattering. Since the molecular
masses of NTD-P1 and NTD-P2 are 7.5 and 7.2 kDa,
respectively, our data suggest that the N-terminal
domain of P1 and P2 also form a 1: 1 heterodimer in
solution (Figure 3D).
Circular dichroism spectrum of NTD-P1/NTD-P2
heterodimer was similar to that of NTD-P2 homodimer,
suggesting that both of them have similar amount of sec-
ondary structure content (Supplementary Figure S1A).
Moreover, NTD-P1 is predicted to have four helices
with pattern similar to NTD-P2 (Supplementary Figure
S1B). Taken together, it is very likely that the
N-terminal dimerization domains of P1/P2 heterodimer
are structurally homologous to NTD-P2. Based on struc-
tural homology, we hypothesized that helix-3 of P1 should
be located away from the P1/P2 dimerization interface.
Noteworthy, the conserved surface charged residues
D37, R38 and K41 in helix-3 of P2 are replaced by
conserved hydrophobic residues, F42, W43 and L46, in
P1 (Figure 4A). It is likely that these residues are
Table 1. NMR and refinement statistics for the 10 best structures of
NTD-P2 homodimer
NMR distance and dihedral restraints
Distance restraints
Total NOE 2652
Total unambiguous NOE 2483
Intramolecular 2345
Intra-residue 1515
Sequential (|i–j|=1) 343
Medium-range (|i–j|< 5) 257
Long-range (|i–j|> 4) 230
Intermolecular 138
Total ambiguous NOE 169
Hydrogen bonds 84
Total dihedral angle restraints
 78
 78
Structure statistics
Violations
Distance restraintsa (A˚) 0.0282±0.0006
Dihedral angle restrainta (

) 0.18±0.06
No. of dihedral angle violation >2 0
No. of distance restraint violation >0.3 A˚ 0
Deviation from idealized geometry
Bond lengthsa (A˚) 0.0043±0.0001
Bond anglesa (

) 0.55±0.01
Impropersa (

) 1.75±0.08
Average pairwise r.m.s.d. (A˚)
Heavy 0.80
Backbone 0.33
aValues of mean and standard deviation were reported.
Figure 1. Molecular mass determination of P2 and NTD-P2 by static
light scattering. Purified P2 and NTD-P2 were loaded to Superdex 75
(GE healthcare) gel filtration column and analysed by static light scat-
tering. The molecular mass of P2 and NTD-P2 were determined to be
22.5 and 13.5 kDa, respectively (monomer molecular masses are 11.5
and 7.2, respectively), showing that both of them form dimer in
solution.
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exposed to surface and play a vital role in binding P0. To
test this hypothesis, we have created a variant of P1
(P1TM) in which these three hydrophobic residues were
substituted to corresponding charged residues in P2
(i.e. F42D/W43R/L46K). To test if the substitutions inter-
fere with P1/P2 heterodimer formation, we mixed
full-length human P2 with P1TM. The complexes of
P1TM/P2 were purified, and loaded to Superdex 200 ana-
lytical gel filtration column. P1TM/P2 eluted as a single
symmetrical peak and their molecular masses determined
by static light scattering were 22±1kDa which is in good
agreement with the theoretical molecular mass of 23 kDa
for 1: 1 binding (Figure 4B). Our results indicate that both
P1 (Figure 3B) and P1TM (Figure 4B) were able to form
heterodimer with P2 and support the conclusion that
helix-3 is not involved in P1/P2 dimerization.
Next, we tested if the substitutions on helix-3 of P1would
affect P-complex formation. Poly-histidine-tagged P0 was
co-refolded with purified P1, P2, P1/P2 or P1TM/P2
complex. In the absence of P1 and P2, P0 was aggregated
and precipitated after refolding (Figure 4C, lanes 1 and 2).
This observation is consistent with previous findings that
purification of P0 alone resulted in aggregation (8). If P0
was co-refolded with P1 and P2, a soluble complex contain-
ing P0/P1/P2was detected (Figure 4C, lanes 3 and 4), which
was then purified by metal-chelating chromatography. The
molecular mass of the complex determined by static light
scattering was 80±1kDa, which is in good agreement with
the theoretical molecular mass of 80 kDa for P0-(P1/P2)2
pentameric complex (Figure 4D). If P1 was added, P0 was
solubilized with P1 (Figure 4C, lanes 5 and 6).
Metal-chelating chromatography showed that P1 was
co-eluted with P0, suggesting P0 forms complex with P1.
The protein sample was further loaded to a Superdex 200
gel filtration column. The P0/P1 complex was eluted in the
void volume, suggesting it forms soluble aggregates. On the
other hand, when P0 was co-refolded with P2, P0 was
precipitated (Figure 4C, lane 7) while P2 remained
soluble in solution (Figure 4C, lane 8), suggesting P2
alone does not form complex with P0. Finally, when P0
was co-refolded with P1TM and P2, P0 was precipitated
(Figure 4C, lane 9) while P1TM formed a soluble complex
with P2 (Figure 4C, lane 10). This observation strongly
suggests that the triple substitutions of the hydrophobic
residues on helix-3 of P1 disrupt the interaction of P1/P2
with P0, and failure to co-refold with P1TM and P2
resulted in precipitation of P0. Taken together, our
results suggest that helix-3 of P1 is not involved in P1/P2
dimerization but takes part in the formation of P-complex
through hydrophobic interaction.
Figure 2. Dimerization mechanism of NTD-P2. (A) Topology of helices in symmetric homodimer NTD-P2. NTD-P2 homodimer consists of four
helices from each chain. Noteworthy, helix-3 is located away from the dimeric interface formed by helices 1, 2 and 4. (B) Stereo-diagram showing the
close-up view of the dimeric interface. (C) Residues in the dimeric interface are highly conserved (shaded black, A5, L8, L9, I26, L27, V30, I32, I55).
Secondary structure elements are indicated above the alignment. (D) Intermolecular NOEs were obtained from the three dimensional 13C F1-filtered,
F3-edited NOESY-HSQC experiment (25) acquired on an asymmetrically labelled NTD-P2 sample. Selected 2D F1-F3 plane at
13C frequency
(24.2 ppm) of L9 CD2 was shown. L9 HD2 was found to have intermolecular NOE cross peaks to S6 HA, I26 HA, A5 HB, V30 HG2 and I32 HD.
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DISCUSSION
Although the ribosomal stalks are present in ribosomes
from all three domains of life, their structural compos-
itions are different. In bacteria, the stalk complex is
constituted by 2–3 copies of L12 dimer binding to L10
via a C-terminal spine helix (3,4,39). In archaeal stalk,
three copies of P1 homodimers bind to P0 via three
helices of the C-terminal spine (5). Although there was
no high resolution structure of any eukaryotic stalk
protein, it is generally believed that two copies of P1/P2
heterodimers bind to the C-terminal of P0 to form a
pentameric P-complex (12). The structure of the dimeriza-
tion domain of human ribosomal protein reported in this
study provides insights into the organization of eukaryotic
stalk.
Structural comparison of the dimerization domains of
eukaryotic, bacterial and archaeal stalk proteins
As expected from the large sequence divergence between
eukaryotic and bacterial stalk proteins, the structure of
NTD-P2 is very different from that of the bacterial L12
dimer. The 30-residues N-terminal domain of L12 consists
of two helices forming a V-shaped hairpin and two anti-
parallel V-shaped a–a hairpins entangled with each other
to form the hydrophobic dimeric interface (4,40,41)
(Figure 5). In contrast, the N-terminal dimerization
domain of P2 (NTD-P2) has about 70 residues and the
dimeric interface is formed by helices 1, 2 and 4 packing
with each other in an antiparallel fashion with helix-3
locating away from the interface.
On the other hand, human NTD-P2 shares structural
and sequence similarity with archaeal P1 protein. The
recent crystal structure of archaeal P0(P1)2(P1)2(P1)2
stalk complex from Pyrococcus horikoshii showed that
each of the P1 (Ph-P1) homodimer binds to C-terminal
spine helix of P0 (Ph-P0) (5). The sequence identity
between the dimerization domains of human P2 and
Ph-P1 is 29%. Similar to NTD-P2, each monomer of
Ph-P1 has four helices. Helix-1 and 2 of the Ph-P1 lay at
the dimerization interface in an antiparallel fashion while
helix-3 is packed away from the interface. The major
Figure 3. P1 and P2 form 1: 1 heterodimer spontaneously and their N-terminal domain is responsible for dimerization. (A) P1/P2 complex was
formed by directly mixing P1 and P2. P2 (lane 1) was mixed with P1 (lane 2) in 1: 1 molar ratio. The presence of an up-shifted band in native gel
electrophoresis (15% gel in Tris/Glycine buffer at pH 8.8) in lane 3 indicates the formation of P1/P2 complex. (B) The protein mixture of P1 and P2
was also loaded to Superdex 200 (GE Healthcare) gel filtration column and analysed by static light scattering. A single peak of P1/P2 complex was
eluted, and the eluted protein was analysed by 15% SDS–PAGE (inset). The molecular mass of the P1/P2 complex was determined to be 24±1kDa
(monomer molecular masses of P1 and P2 are 11.5 and 11.6 kDa, respectively), showing that they form 1: 1 heterodimer in solution. (C) P1/P2
heterodimer is more stable than P2 homodimer. Conformational stability of P2 homodimer and P1/P2 heterodimer was determined by urea-induced
denaturation experiment. Mid-point of transition and m-values were 1.7±0.2M and 3.9±0.4 kJ/mol/M for P2 homodimer, and 4.6±0.3M,
2.8±0.4 kJ/mol/M for P1/P2 heterodimer. Free energy of unfolding were 7±1kJ/mol for P2 homodimer and 13±2kJ/mol for P1/P2 heterodimer.
(D) N-terminal domain of P1 and P2 forms 1: 1 heterodimer in solution. Purified NTD-P1/NTD-P2 complex was loaded to Superdex 75 column. The
molecular mass of the complex estimated by static light scattering was 14.8±0.5 kDa, suggesting the formation of 1: 1 heterodimer. The inset shows
SDS–PAGE analysis of purified NTD-P1/NTD-P2 complex. The theoretical molecular masses of monomeric NTD-P1 and NTD-P2 are 7.5 and
7.2 kDa, respectively.
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structural differences are found on helix-4. In human P2,
helix-4 adopts a closed conformation in which it packs on
helix-1 and 3 forming an intact hydrophobic core. In
contrast, helix-4 of Ph-P1 adopts an open conformation
that exposes a hydrophobic pocket for binding of Ph-P0
(Figure 5). It is likely that the structure of free Ph-P1
homodimer resembles the structure of human NTD-P2
reported here, and a ‘lid-opening’ motion of helix-4 is
required for Ph-P1 to bind Ph-P0.
Insights into structural organization of eukaryotic stalk
complex
In contrast to archaeal stalk complex, eukaryotic P0 binds
heterodimers of P1/P2 instead of homodimers of P1 or P2
(7,8). Consistent with previous studies, here we show that
while eukaryotic P2 alone forms homodimer in solution,
it forms P1/P2 heterodimer spontaneously in the presence
of P1 (Figure 3) (8,21,22,42,43). We have showed that
the stability (as measured by free energy of unfolding) of
human P1/P2 heterodimer is higher than that of P2
homodimer. Our results are consistent with previous
findings that P1/P2 retains a higher proportion of
dimeric form than P2 homodimer in mass spectrometry
spectra (22). The fact that P1/P2 heterodimer is more
stable than P2 homodimer suggests that P2 forms
stronger interaction with P1. This allows P1 to dissociate
P2 homodimer spontaneously to form P1/P2 heterodimer,
which then binds to P0.
Homology modelling of P1/P2 heterodimer predicts
that three exposed polar residues on helix-3 of P2 are
replaced by conserved hydrophobic residues in P1. As a
result, P1/P2 heterodimer is asymmetrical in the sense that
the surface of helix-3 on the P1 side is hydrophobic, while
that on the P2 side is hydrophilic (Supplementary Figure
S1B and C). Based on this model, we correctly predicted
that these conserved hydrophobic residues are not
involved in the formation of P1/P2 heterodimer, but
play an important role in anchoring P1/P2 heterodimer
to P0 (Figure 4). Replacing these hydrophobic residues
with hydrophilic ones disrupted the formation of eukary-
otic stalk complex.
Figure 4. Conserved hydrophobic residues on helix-3 of P1 is responsible for P0 binding but not for P1/P2 dimerization. (A) Three conserved
charged residues (D37, R38 and K41) on helix-3 of human P2 were found to be substituted by conserved hydrophobic residues (F42, W43 and L46)
in P1. A triple substituted variant of P1 (P1TM, F42D/W43R/L46K) was constructed to test the role of these residues in P-complex formation. (B)
P1TM can interact with P2 to form 1: 1 heterodimer. P1TM was mixed with P2 in 1: 1 molar ratio, and was then loaded to Superdex 200 (GE
Healthcare) gel filtration column and analysed by static light scattering. A single peak of P1TM/P2 complex was eluted, and the eluted protein was
analysed by 15% SDS–PAGE (inset). The molecular mass of P1TM/P2, estimated by static light scattering, suggests the formation of 1: 1
heterodimer. (C) Conserved residues on helix-3 of P1 are involved in binding P0. Poly-histidine-tagged P0 (HisP0) was refolded alone (lanes 1
and 2), with P1/P2 (lanes 3 and 4), with P1 (lanes 5 and 6), with P2/P2 (lanes 7 and 8) or with P1TM/P2 (lanes 9 and 10). After refolding, the protein
samples were centrifuged. The pellet (lanes 1, 3, 5, 7 and 9) and the soluble fractions (lanes 2, 4, 6, 8 and 10) were analysed by 15% SDS–PAGE. (D)
P0, P1 and P2 form pentameric P-complex in 1: 2: 2 ratio. The refolded complex of P0/P1/P2 (Figure 4C, lane 4) was first purified by metal-chelating
chromatography and then loaded to Superdex 200 (GE Healthcare) gel filtration column and analysed by static light scattering. The molecular mass
of the P-complex was determined to be 80 kDa, which is consistent with the stoichiometry of P0:P1:P2=1: 2: 2 for HisP0, P1 and P2 having
molecular masses of 34, 11.5 and 11.6 kDa, respectively.
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How do these conserved residues on helix-3 of P1 con-
tribute to the formation of P-complex? In the crystal struc-
ture of the archaeal stalk complex, Ph-P0 binds to three
copies of Ph-P1 homodimers, and the helix-3 of P1 makes
contacts with helix-3 of adjacent Ph-P1 homodimers (5)
(Supplementary Figure S2A). In contrast, eukaryotic P0
binds two copies of P1/P2 heterodimers. The asymmetry
of P1/P2 heterodimer results in four possibilities of topo-
logical arrangements: (i) P1/P2:P1/P2; (ii) P1/P2:P2/P1;
(iii) P2/P1:P2/P1; (iv) P2/P1:P1/P2 (Supplementary
Figure S2B). All of these arrangements are consistent
with the findings that P0 can be cross-linked to both P1
and P2 (6). If the eukaryotic stalk complex has similar
structural organization to archaeal stalk complex, our
results favour the topological arrangement of P2/P1:P1/
P2 (Figure 6A), in which two helix-3 from adjacent P1 are
facing each other. Homology modelling of the P-complex
suggested that the conserved hydrophobic residues
(Phe42, Trp43, Leu46) on helix-3 of P1 can form hydro-
phobic interactions with adjacent P1 and with a conserved
Tyr-Pro motif of P0 at the loop between the two spine
helices (Supplementary Figure S3A–C). This model is con-
sistent with the observation that Trp43 in helix-3 of P1 is
buried in the yeast pentameric P-complex (44).
Substituting these conserved residues with hydrophilic
one from P2 will break the hydrophobic interactions
between P0 and P1, and introduce charge–charge repul-
sion between adjacent P1 (Supplementary Figure S3B),
leading to the disruption of eukaryotic stalk complex
(Figure 4). This model also predicts that the binding of
two P1/P2 heterodimers are cooperative, which is consist-
ent with previous finding that removal of one of the two
P1/P2 binding sites from P0 weaken its interaction with
P1/P2 (19).
In the cryo-EM map of canine 80S ribosome (35), there
is an un-interpreted density at the extended stalk region
(Figure 6B). Initial inspection suggested that the density is
big enough to accommodate two copies of P1/P2
heterodimers. A model of the dimerization domains of
P-complex, with topological arrangement of P2/P1:P1/
P2, was generated by homology modelling
(Supplementary Figure S3A). This model can be nicely
fitted into the cryo-EM density at the extended stalk
region (Figure 6B). Similarly, the model can also be
fitted to the cryo-EM map of yeast 80S ribosome in
complex with elongation factor 2 (45) (Supplementary
Figure S4). There is a conserved motif
SDDDMGFGLFD at the C-termini of eukaryotic
P-proteins, which is involved in functional binding of
elongation factors (12) and ribosomal inactivating
proteins (13). In the crystal structure of the C-terminal
motif in complex with a ribosomal inactivating protein,
trichosanthin, the GFGLF motif adopts a type-II b-turn
conformation that docks the Leu-Phe residues into a small
hydrophobic pocket of trichosanthin (16). The C-terminal
conserved motif is linked to the dimerization domain of
P-proteins via a flexible linker. As showed in Figure 6B,
the flexible C-terminal tails of P-proteins are protruding
out of the extended stalk and are in positions for making
interactions with bound translation factors and recruiting
translation factors to the ribosome (12,46).
Despite the differences in sequence and structural com-
position, stalk complexes from bacteria, archaea and eu-
karyotes share similar functional organization
(Supplementary Figure S5). They all have a ‘scaffold’
protein (L10 in bacteria and P0 in archaea and eukary-
otes) that has an N-terminal domain for anchoring to the
rRNA, and a spine helix that binds dimers of small ribo-
somal stalk proteins (L12 in bacteria, P1 in archaea and
P1/P2 in eukaryotes). In these small ribosomal stalk
proteins, the N-terminal dimerization domain responsible
for interacting with the scaffold proteins (L10 or P0) is
connecting via a flexible linker to the C-terminal domain
responsible for binding translation factors (4,5,12,47). As
a result, stalk complexes from all three kingdoms have
multiple copies of the C-terminal domain protruding out
from the ribosomal stalk. This similarity in functional or-
ganization is likely to reflect a common mechanism in
translation factor recruitment. For example, it has been
suggested that multiple copies of the C-terminal domain
increase the probability of encountering translation
factors in the cytoplasm, and fetch them to the factor
binding site (4,5).
Figure 5. Structural comparison among eukaryotic, bacterial and archaeal stalk proteins. The structure of human P2 homodimer (green) is
compared with the structure of bacterial (Thermotoga maritima, orange) L12 homodimer (4,40,41) and of archaeal (Pyrococcus horikoshii, cyan)
P1 homodimer (5). The C-terminal spine helices of bacteria L10 and archaeal P0 are in purple and magenta, respectively.
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It has been observed that while P0 can be solubilized by
P1, it cannot form a soluble complex with the addition of
P2 alone (7,42). Our co-refolding experiments came to the
same conclusion (Figure 4C). Based on this observation,
another model for eukaryotic stalk complex was proposed
previously (7). In this model, P1 is located between P0 and
P2, and serves as a bridge between them in the eukaryotic
stalk complex (Supplementary Figure S6). If this topo-
logical arrangement is correct, the conserved hydrophobic
residues on helix-3 of eukaryotic P1 may be involved in
direct interaction with P0. Alternatively, the same obser-
vation can be explained by our model of P-complex
(Supplementary Figure S3). Similar to P1TM, the forma-
tion of P0/P2 complex may be prevented by the hydrophil-
ic residues on helix-3 of P2. In the case of the P0/P1
complex, it formed soluble aggregates in our hand. If
the P0/P1 complex is structurally homologous to the
archaeal stalk complex, the exposed conserved hydropho-
bic residues on helix-3 of P1 may lead to the observed
aggregation of P0/P1 complex (Supplementary Figure
S3D). Structure determination of eukaryotic P-complex,
which is underway in our laboratory, will provide a
definite answer to the structural organization of eukary-
otic stalk.
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